TREVICTA

Prolonged-release suspension for injection, 263mg/1.315ml
RxActive license

Active substance (INN)

paliperidone

Pharmaceutical form

Pharmaceutical formProlonged-release suspension for injection
Strength263mg/1.315ml
PackagingUkupno 1 napunjeni injekcioni špric sa 1.315ml suspenzije za injekciju sa produženim oslobađanjem (sa 2 igle) u kartonskoj kutiji
ManufacturerJanssen Pharmaceutica N.V., Belgium
Therapeutic groupNervous system (N05AX13)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateSeptember 10, 2018

Analogs in Montenegro

13

Other medicines with the same active substance

LESCITRx
Prolonged-release suspension for injection in pre-filled syringe, 50mgStada Arzneimittel AG
LESCITRx
Prolonged-release suspension for injection in pre-filled syringe, 75mgStada Arzneimittel AG
LESCITRx
Prolonged-release suspension for injection in pre-filled syringe, 150mgStada Arzneimittel AG
LESCITRx
Prolonged-release suspension for injection in pre-filled syringe, 100mgStada Arzneimittel AG
PALIPERIDON TEVARestricted
Prolonged-release suspension for injection, 50mg/0.5mlActavis ehf.
PALIPERIDON TEVARestricted
Prolonged-release suspension for injection, 100mg/mlActavis ehf.
PALIPERIDON TEVARestricted
Prolonged-release suspension for injection, 75mg/0.75mlActavis ehf.
PALIPERIDON TEVARestricted
Prolonged-release suspension for injection, 150mg/1.5mlActavis ehf.
TREVICTARx
Prolonged-release suspension for injection, 350mg/1.75mlJanssen Pharmaceutica N.V.
TREVICTARx
Prolonged-release suspension for injection, 525mg/2.625mlJanssen Pharmaceutica N.V.
XEPLIONRx
Prolonged-release suspension for injection, 75mgJanssen Pharmaceutica N.V.
XEPLIONRx
Prolonged-release suspension for injection, 100mgJanssen Pharmaceutica N.V.
XEPLIONRx
Prolonged-release suspension for injection, 150mgJanssen Pharmaceutica N.V.
Source: CInMED register